Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
March 29, 2025
ACC 2025 Preview: Key Cardiology Highlights to Watch
March 27, 2025
AMWC 2025 Preview: Anti-Aging and Aesthetic Medicine Highlights to Watch
March 26, 2025
ELCC 2025 Preview: Key Lung Cancer Highlights to Watch
March 25, 2025
Obesity Weekly News – March 25th 2025
March 24, 2025
Hematology Weekly News – March 24th 2025
March 24, 2025
Oncology Weekly Update – March 24th 2025
March 21, 2025
EAU 2025 Preview: Key Urology Highlights to Watch
March 20, 2025
CONy 2025 Preview: Key Neurology Highlights to Watch
March 18, 2025
Obesity Weekly News – March 18th 2025
March 17, 2025
Hematology Weekly News – March 17th 2025
March 17, 2025